Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
Healthy Volunteers
NCT05047133

Effect of Early Administration of TXA in Adult Hip Fractures

Led by Ascension Health · Updated on 2021-09-16

170

Participants Needed

1

Research Sites

43 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective clinical study designed to assess blood loss in intracapsular and extracapsular hip fractures undergoing operative fixation at a Level II trauma center. It is well established in the orthopedic literature that tranexamic acid (TXA) decreases blood loss and need for postoperative blood transfusion in hip fracture patients as well as total joint arthroplasty patients. A typical dosing pattern, and the dosing pattern employed at our institution, is 1 gram IV infused prior to incision followed by 1 gram IV infused at the time of wound closure.

CONDITIONS

Official Title

Effect of Early Administration of TXA in Adult Hip Fractures

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years old or older
  • Acute hip fracture patients
  • Patients undergoing operative fixation for hip fracture
Not Eligible

You will not qualify if you...

  • Polytrauma patients
  • Previous operation on the same hip
  • Patients with blood clotting disorders such as Factor V Leiden or Sickle Cell Anemia
  • Patients with a history of thromboembolic events, stroke, cardiac stents, or heart attack within the past 6 months
  • History of seizure disorder
  • Patients currently on birth control
  • Pregnant women
  • Prisoners
  • Patients with active thromboembolic disease such as deep vein thrombosis, pulmonary embolism, heart attack, or stroke

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ascension Genesys Hospital

Grand Blanc, Michigan, United States, 48439

Actively Recruiting

Loading map...

Research Team

J

Jacob Hinkley, DO, MS

CONTACT

J

Jacob Lytle, DO

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here